Literature DB >> 20043239

TDP-43 dimerizes in human cells in culture.

Yuki Shiina1, Kunimasa Arima, Hiroko Tabunoki, Jun-ichi Satoh.   

Abstract

TAR DNA-binding protein-43 (TDP-43) is a 43-kDa nuclear protein involved in regulation of gene expression. Abnormally, phosphorylated, ubiquitinated, and aggregated TDP-43 constitute a principal component of neuronal and glial cytoplasmic and nuclear inclusions in the brains of frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS), although the molecular mechanism that triggers aggregate formation remains unknown. By Western blot analysis using anti-TDP-43 antibodies, we identified a band with an apparent molecular mass of 86-kDa in HEK293, HeLa, and SK-N-SH cells in culture. It was labeled with both N-terminal-specific and C-terminal-specific TDP-43 antibodies, enriched in the cytosolic fraction, and the expression levels were reduced by TDP-43 siRNA but unaltered by treatment with MG-132 or by expression of ubiqulin-1 or casein kinase-1. By immunoprecipitation analysis, we found the interaction between the endogenous full-length TDP-43 and the exogenous Flag-tagged TDP-43, and identified the N-terminal half of TDP-43 spanning amino acid residues 3-183 as an intermolecular interaction domain. When the tagged 86-kDa tandemly connected dimer of TDP-43 was overexpressed in HEK293, it was sequestered in the cytoplasm and promoted an accumulation of high-molecular-mass TDP-43-immunoreactive proteins. Furthermore, the 86-kDa band was identified in the immunoblot of human brain tissues, including those of ALS. These results suggest that the 86-kDa band represents dimerized TDP-43 expressed constitutively in normal cells under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20043239     DOI: 10.1007/s10571-009-9489-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  27 in total

1.  Identification of casein kinase-1 phosphorylation sites on TDP-43.

Authors:  Fuyuki Kametani; Takashi Nonaka; Takehiro Suzuki; Tetsuaki Arai; Naoshi Dohmae; Haruhiko Akiyama; Masato Hasegawa
Journal:  Biochem Biophys Res Commun       Date:  2009-03-13       Impact factor: 3.575

2.  TDP-43: an emerging new player in neurodegenerative diseases.

Authors:  I-Fan Wang; Lien-Szu Wu; C-K James Shen
Journal:  Trends Mol Med       Date:  2008-10-15       Impact factor: 11.951

3.  Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression.

Authors:  Jason B Tatom; David B Wang; Robert D Dayton; Omar Skalli; Michael L Hutton; Dennis W Dickson; Ronald L Klein
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

4.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

5.  Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.

Authors:  Takashi Nonaka; Tetsuaki Arai; Emanuele Buratti; Francisco E Baralle; Haruhiko Akiyama; Masato Hasegawa
Journal:  FEBS Lett       Date:  2008-12-25       Impact factor: 4.124

6.  Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation.

Authors:  Matthew J Winton; Lionel M Igaz; Margaret M Wong; Linda K Kwong; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2008-02-27       Impact factor: 5.157

7.  TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing.

Authors:  Emanuele Buratti; Antonia Brindisi; Maurizio Giombi; Sergio Tisminetzky; Youhna M Ayala; Francisco E Baralle
Journal:  J Biol Chem       Date:  2005-09-12       Impact factor: 5.157

8.  Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function.

Authors:  Youhna M Ayala; Sergio Pantano; Andrea D'Ambrogio; Emanuele Buratti; Antonia Brindisi; Caterina Marchetti; Maurizio Romano; Francisco E Baralle
Journal:  J Mol Biol       Date:  2005-05-06       Impact factor: 5.469

9.  Structural determinants of the cellular localization and shuttling of TDP-43.

Authors:  Youhna M Ayala; Paola Zago; Andrea D'Ambrogio; Ya-Fei Xu; Leonard Petrucelli; Emanuele Buratti; Francisco E Baralle
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

10.  Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43.

Authors:  Yong-Jie Zhang; Ya-fei Xu; Chad A Dickey; Emanuele Buratti; Francisco Baralle; Rachel Bailey; Stuart Pickering-Brown; Dennis Dickson; Leonard Petrucelli
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

View more
  40 in total

Review 1.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.

Authors:  Lin Guo; James Shorter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

Review 2.  The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo.

Authors:  Hiroki Sasaguri; Jeannie Chew; Ya-Fei Xu; Tania F Gendron; Aliesha Garrett; Chris W Lee; Karen Jansen-West; Peter O Bauer; Emilie A Perkerson; Jimei Tong; Caroline Stetler; Yong-Jie Zhang
Journal:  Brain Res       Date:  2016-05-04       Impact factor: 3.252

3.  TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.

Authors:  Mauro Montalbano; Salome McAllen; Filippa Lo Cascio; Urmi Sengupta; Stephanie Garcia; Nemil Bhatt; Anna Ellsworth; Eric A Heidelman; Omar D Johnson; Samantha Doskocil; Rakez Kayed
Journal:  Neurobiol Dis       Date:  2020-10-14       Impact factor: 5.996

4.  An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution.

Authors:  Li Zhu; Meng Xu; Mengxue Yang; Yanlian Yang; Yang Li; Jianwen Deng; Linhao Ruan; Jianghong Liu; Sidan Du; Xuehui Liu; Wei Feng; Kazuo Fushimi; Eileen H Bigio; Marsel Mesulam; Chen Wang; Jane Y Wu
Journal:  Hum Mol Genet       Date:  2014-08-11       Impact factor: 6.150

5.  Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.

Authors:  Carlos J Rodriguez-Ortiz; Hitomi Hoshino; David Cheng; Liqun Liu-Yescevitz; Mathew Blurton-Jones; Benjamin Wolozin; Frank M LaFerla; Masashi Kitazawa
Journal:  Am J Pathol       Date:  2013-06-05       Impact factor: 4.307

6.  Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.

Authors:  Miguel Mompeán; Valentina Romano; David Pantoja-Uceda; Cristiana Stuani; Francisco E Baralle; Emanuele Buratti; Douglas V Laurents
Journal:  J Biol Chem       Date:  2017-05-31       Impact factor: 5.157

7.  S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD.

Authors:  Elaine Pirie; Chang-Ki Oh; Xu Zhang; Xuemei Han; Piotr Cieplak; Henry R Scott; Amanda K Deal; Swagata Ghatak; Fernando J Martinez; Gene W Yeo; John R Yates; Tomohiro Nakamura; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

Review 8.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

9.  The Neurotoxic TAU45-230 Fragment Accumulates in Upper and Lower Motor Neurons in Amyotrophic Lateral Sclerosis Subjects.

Authors:  Claudia R Vintilescu; Sana Afreen; Ashlee E Rubino; Adriana Ferreira
Journal:  Mol Med       Date:  2016-08-03       Impact factor: 6.354

Review 10.  Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.

Authors:  C Veyrat-Durebex; P Corcia; A Dangoumau; F Laumonnier; E Piver; P H Gordon; C R Andres; P Vourc'h; H Blasco
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.